)
)
David Yadin
Associate Director, Research,
Alchemab Therapeutics
David is Associate Director of Research at Alchemab Therapeutics and has more than 15 years of experience in both academia and industry. While working in biopharmaceutical companies, he has developed expertise in antibody discovery, biologics engineering and next generation sequencing technologies, including single cell sequencing.
At Alchemab, he has been integral to building and innovating the platform. He leads a team working on advanced methods for sequencing patient immune repertoires and identifying antibody targets.